NMN Research Frontier (Vol. 02) What is NAD Research?

Apr 2
6 min read

Updated: Apr 9

The Science Behind Longevity ·

What NAD+ Does · Where the World is Looking

NMN RESEARCH FRONTLINE — MONTHLY SERIES — VOL. 02 OF 12

Right now, while you read this, your cells are doing something quietly remarkable. They are repairing DNA, converting food into energy, managing inflammation, and keeping your internal clock ticking — all at once, all without your awareness.

Almost all of it depends

on a single molecule called NAD+

Your body has always made it — but it makes less as the years go by. Research shows that NAD+ levels decline significantly with age, with reductions observed across muscle, liver, brain, and blood. This gradual decline is now understood to be one of the central biological factors behind changes in energy, recovery, and sleep that many people experience as they get older.

Scientists around the world are studying this process — not as something inevitable, but as something measurable, and potentially modifiable. This month, we look at what NAD+ actually is, what it does, and where the science is heading.

01 — Research Theme

THE MOLECULE

NAD+

The Molecule That Powers Cellular Life

NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in every living cell. It plays a central role in maintaining cellular function across the entire body — not through one process, but through hundreds of interconnected biological reactions simultaneously.

What makes NAD+ especially important is not just what it does, but how broadly it operates. It supports energy production, DNA repair, and cellular regulation all at once — making it unlike most other molecules, which tend to serve narrower functions.

500+

Enzymatic reactions involving NAD+

10–50%

Decline observed across tissues by midlife

Every cell

in the human body depends on NAD+

NAD+ levels decline with age. Studies have reported reductions ranging from approximately 10% to 50%, depending on tissue type and methodology. This decline has been consistently observed across muscle, liver, brain, and blood.

As NAD+ levels fall, multiple systems begin to slow — not individually, but all at once. This is what makes the decline biologically significant: it is a systemic change, not a localised one.

“NAD+ is not just a single molecule with a single job. It is the connective tissue between energy, repair, and regulation — the molecule that keeps cellular systems aligned.”

— TA Medical NMN Research Team

02 — Explanation

HOW IT WORKS

What NAD+ Does —

And Why It Matters for Daily Life

NAD+ functions as a central regulator of cellular metabolism. Its roles span five interconnected areas — and all five are affected simultaneously when levels decline:

Energy Production	Acts as an electron carrier in mitochondria, converting nutrients from food into ATP — the usable energy of every cell. When NAD+ is low, this conversion becomes less efficient across all organs.
DNA Repair	Powers PARP enzymes that detect and repair daily DNA damage. Every cell sustains thousands of DNA breaks per day — NAD+ is what funds the repair response.
Longevity Proteins	Activates sirtuins — proteins that regulate aging, inflammation, and cellular stress response. Often called "longevity proteins" because of their role in extending healthy lifespan in research.
Brain & Sleep	Supports neuronal energy metabolism and regulation of circadian rhythm — the internal 24-hour clock. NAD+ is directly involved in keeping sleep-wake cycles aligned with biological time.
Immunity	Fuels immune cell activation and recovery. During illness or inflammation, immune cells consume NAD+ rapidly — making adequate levels important for response speed and recovery.

What a Decline Looks Like in Practice

These functions are interconnected. When NAD+ levels decline, energy production becomes less efficient, repair mechanisms weaken, and regulatory systems lose precision — all at the same time. In practical terms, this may present as:

Reduced energy and stamina Mitochondrial efficiency falls as NAD+ declines, affecting energy output across all organs — including muscle, heart, and brain.	Slower recovery Both physical recovery from exercise and cellular recovery from daily damage slow when PARP enzymes lack sufficient NAD+ to function fully.
Changes in sleep quality NAD+ plays a direct role in circadian rhythm regulation. Declining levels have been associated with disruptions in the sleep-wake cycle in aging research.	Increased physiological stress With less sirtuin activity, the body's regulation of inflammation and stress response weakens — contributing to reduced resilience that many notice with age.

These changes are not random. They reflect a biological system operating with reduced cellular support. The key insight from current research is that addressing NAD+ decline may allow multiple systems to improve simultaneously — rather than targeting each issue separately.

03 — Global Research Trends

WHERE THE WORLD IS LOOKING

A Global Focus on NAD+ Biology

NAD+ research has expanded rapidly over the past decade, transitioning from foundational laboratory studies to human clinical trials. The breadth of this research — spanning metabolism, neuroscience, genetics, and aging biology — reflects growing scientific consensus around its importance.

Japan	Clinical leadership and manufacturing quality Home to the world's first human NMN clinical trials (Keio University), and ongoing Werner syndrome NAD+ clinical research at Chiba University (2025). Japan leads in clinical validation and high-purity NMN manufacturing standards.
United States	Foundational science and metabolic research Harvard Medical School (Dr. David Sinclair) and Washington University (Dr. Shinichiro Imai) established foundational work on sirtuins and NAD metabolism. Ongoing studies focus on metabolic health, insulin sensitivity, and aging biology.
Europe	Large-scale reviews and neurological research Norway and other European institutions have led landmark systematic reviews, including the 2026 Nature Aging publication. Active research into Parkinson's and Alzheimer's disease.
Asia	Scale and personalisation China and Singapore have contributed large-scale human studies and dose optimisation research. AI-driven approaches to understanding individual NAD+ variability are emerging from this region.

The shift to

human trials

After years of promising animal studies, the field is now generating its first wave of human clinical data — a critical transition for translating preclinical findings into practical outcomes.

From theory to intervention

Recent global reviews identify NAD+ as a central target in aging biology, with growing emphasis on measurable, translatable interventions.

Individual

variability

Emerging research highlights that NAD+ response varies significantly between individuals — driving interest in personalised approaches.

04 — Expert Commentary

WHY THIS MATTERS

The Bigger Picture

What makes NAD+ research compelling is not a single discovery, but the convergence of findings across multiple scientific disciplines — including metabolism, genetics, and aging biology.

NAD+ sits at the intersection of these systems. Its decline affects multiple biological processes simultaneously, which helps explain why aging tends to present as a broad, systemic change rather than a single isolated issue.

“When you reverse aging, the diseases of aging go away or are cured. NAD+ is one of the most important levers we have found so far.”

— Dr. David Sinclair, Harvard Medical School

The most important development in recent years is the transition from animal studies to human research. Early clinical findings suggest that NAD+ metabolism can be influenced in measurable ways — though many questions remain regarding long-term outcomes and individual variability.

The field is evolving rapidly. But the scientific foundation is increasingly clear: NAD+ is not a supplement trend. It is a fundamental molecule in cellular biology, and understanding its role in aging may be one of the most consequential areas of health science today.

EXPERT COMMENTARY

This commentary draws on established research in NAD+ biology, including foundational work on sirtuins and NAD metabolism by Dr. Shinichiro Imai (Washington University) and Dr. David Sinclair (Harvard Medical School), as well as recent international reviews published in Nature Aging and related journals.

This article is part of the TA Medical NMN Research Frontline series — a 12-month educational programme exploring the science behind NMN and NAD+. Content is produced for informational and research communication purposes and does not constitute medical advice.

REFERENCES & RESEARCH SOURCES

1. Yoshino, J. et al. (2018). NAD+ intermediates: The biology and therapeutic potential of NMN and NR.. Cell Metabolism, 27(3), 513–528.

2. Zhang, J. et al. (2026). Emerging strategies, applications and challenges of targeting NAD+ in the clinic.. Nature Aging, 5(9), 1704.

3. Imai, S. (2025). NAD World 3.0.. npj Aging.

4. Koshizaka, M. et al. (2025). Nicotinamide Riboside in Werner Syndrome: Double-Blind Randomized Trial.. Aging Cell.

5. Covarrubias, A. J. et al. (2021). NAD+ metabolism and its roles in cellular processes during ageing.. Nature Reviews Molecular Cell Biology.

6. Cantó, C. et al. (2015). NAD+ metabolism and the control of energy homeostasis.. Cell Metabolism, 22(1), 31–53.

7. Verdin, E. (2015). NAD+ in aging, metabolism, and neurodegeneration.. Science, 350(6265), 1208–1213.

Disclaimer: This content is produced for research communication and informational purposes. It reflects the current state of published scientific literature and does not constitute medical advice. Please consult a healthcare professional for personal health decisions.